Skip to main navigation Skip to search Skip to main content

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

  • RECOVERY Collaborative Group

    Research output: Contribution to journal › Article › peer-review

    294 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial'. Together they form a unique fingerprint.
    Sort by

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science